Chair
Hailin Liu (Deputy Director General, China Medicinal Biotech Association, China)

Co-Chair
Ziren Xiao (Deputy Director General, China Medicinal Biotech Association, China)

Executive Chair and Secretary General
Xiaodan Mei (President, Dalian BIT Life Sciences, Inc.)

Deputy Secretary General
Zhaohui Wu (Assistant Secretary General, China Medicinal Biotech Association, China)

Yuefen Chang (Assistant Secretary General, China Medicinal Biotech Association, China)

Membership
Yong Wen (Superior, Membership Department of China Medicinal Biotech Association, China)

Program Leader
Helen Zhao (Director, Dalian BIT Life Sciences, Inc.)

Program Coordinator
Vicky Zhu (Group Member of Dalian BIT Life Sciences, Inc.)
King Liu (Group Member of Dalian BIT Life Sciences, Inc.)
Sean Song (Group Member of Dalian BIT Life Sciences, Inc.)
Jacky Zhao (Group Member of Dalian BIT Life Sciences, Inc.)

SAB Members
Faming Zhang, President, Crown Bioscience, USA
Bob Irving, CEO, Interstitial NS and COO, Nanotechnology Victoria Ltd, Australia
Alex Wu, CEO, Crown Bioscience, Inc. USA
Uwe Gottschalk, VP, Sartorius Stedim Biotech, Germany
Phil Sass, COO, Morphotek, Inc., USA
Peter Buckel, CEO, SuppreMol GmbH, Germany
Agamemnon A. Epenetos, FRCP, Consultant Oncologist, United Kingdom
Lida Tang, president, Tianjin Institute of Pharmaceutical Research, China
Andrew Porter, Professor, university of Aberdeen, UK
Barry Marrs, CTO, Athena Biotechnologies, Inc., USA
Peter Senter, VP, Seattle Genetics, USA
Victor S. Goldmacher, Senior Director, ImmunoGen, Inc., USA
Howard C. Birndorf, Chairman and CEO, Nanogen, Inc., USA
Horst Lindhofer, CEO, Trion Pharma, Germany
Steffen Nock, Acting CEO, Arana Therapeutics Limited, Australia
Frank Zhang, CEO, Genscript Corporation, USA
Peter Park, Senior Director, ImmunoGen, Inc., USA
Nicolas Fischer, Head of Protein Engineering, NovImmune SA, Switzerland
Alan Liu, President, CytoMol Corporation, USA
Didier Decaudin, Professor, Institut Curie, France
David R. Buckler, Director, Research Alliances, Dyax Corp, USA
Julian Burke, Chief Scientific Officer, Genetix Group plc, United Kingdom
Paul M Watt, VP Research, CSO, Phylogica Ltd, Australia
E.P. Meulenberg, CEO, Elti Support, Netherlands
Reza Mazaheri (Bijan), President & Scientific Director, ID Labs Inc / ID Labs Biotechnology, Canada
Dennis M. Kraichely, Principal Research Scientist and Group Leader, Pharmaceutical Development & Marketed Product Support, Centocor R&D, Inc. (A Johnson & Johnson Company)
Laura Andrews, Vice President Pharm/Tox, Genzyme Corporation, USA
Patrick Liu, Associate Director, Genentech, Inc., USA
Willem 'Pim' Stemmer, CEO and Founder, Amunix Inc., USA
S Howell, CEO, Innova Partnerships Ltd, UK
Mei-Yun Zhang, Scientist, CCRNP, NCI-Frederick, NIH, USA
Leodevico (Vic) L. Ilag, COO, Patrys Ltd, Australia